Caring Cross, a 501(c)(3) non-profit dedicated to improving access to advanced therapies, and Boston Children's Hospital today announced a collaboration to provide a sustainable, affordable pathway ...

Researchers from Leiden University Medical Center (LUMC) and the Leiden-based biotech company Ncardia have joined forces to ...

Fred Hutchinson researchers are testing a simple idea with surprisingly big potential: a special type of foam that makes gene therapy more efficient.

Caring Cross, a 501(c)(3) non-profit dedicated to improving access to advanced therapies, and Boston Children’s Hospital have announced a collaboration to provide a sustainable, affordable pathway for ...

A small number of cancer cells with the ability to change their identities and behaviors appear to be a key driver of cancer ...

Panama is no longer just a canal and a financial hub; it's now the epicenter of regenerative medicine's future.

Rehabilitation Specialists of Monroe introduces shockwave therapy for chronic pain. No surgery, minimal downtime, lasting ...

Exicure, Inc. (Nasdaq: XCUR), a clinical-stage biotechnology company developing therapeutics for hematologic diseases, today announced that it will present a poster at the upcoming 2026 Tandem ...

Stem cell therapy has been around for treating different types of blood cancer, but is a relatively new form of regenerative ...

The approval of this accelerated pathway not only demonstrates the FDA’s full recognition of the quality, safety, and efficacy of the Phase 1 clinical data of hNPC01 in China, but also will ...

Medicaid is doing a novel payment system for the new, promising and expensive sickle cell treatment. It may become a model ...

Stem cell IVF could enable same-sex couples and single parents to have genetically related children. It’s time to think ...